127 related articles for article (PubMed ID: 12392821)
1. Haem polymerase as a novel target of antimalarial action of cyproheptadine.
Agrawal R; Tripathi R; Tekwani BL; Jain SK; Dutta GP; Shukla OP
Biochem Pharmacol; 2002 Nov; 64(9):1399-406. PubMed ID: 12392821
[TBL] [Abstract][Full Text] [Related]
2. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
[TBL] [Abstract][Full Text] [Related]
3. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
4. The chemotherapy of rodent malaria. LIX. Drug combinations to impede the selection of drug resistance, Part 3: Observations on cyproheptadine, an antihistaminic agent, with chloroquine.
Peters W; Robinson BL; Stewart LB; Butcher GA
Ann Trop Med Parasitol; 2000 Oct; 94(7):689-97. PubMed ID: 11144810
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
[TBL] [Abstract][Full Text] [Related]
6. Blood schizontocidal activity of azithromycin and its combination with alpha/beta arteether against multi-drug resistant Plasmodium yoelii nigeriensis, a novel MDR parasite model for antimalarial screening.
Tripathi R; Dhawan S; Dutta GP
Parasitology; 2005 Sep; 131(Pt 3):295-301. PubMed ID: 16178350
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
Tripathi R; Pandey SK; Rizvi A
Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
[TBL] [Abstract][Full Text] [Related]
8. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis.
Singh N; Puri SK
Acta Trop; 2000 Nov; 77(2):185-93. PubMed ID: 11080509
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers.
Peters W; Robinson BL; Mittelholzer ML; Crevoisier C; Stürchler D
Ann Trop Med Parasitol; 1995 Oct; 89(5):465-8. PubMed ID: 7495359
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Benito A; Roche J; Molina R; Amela C; Alvar J
Am J Trop Med Hyg; 1995 Nov; 53(5):526-31. PubMed ID: 7485712
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis.
Dutta GP; Bajpai R; Vishwakarma RA
Pharmacol Res; 1989; 21(4):415-9. PubMed ID: 2771860
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
Goldring JD; Padayachee T; Ismail I
Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial interaction of quinine and quinidine with clarithromycin.
Pandey SK; Dwivedi H; Singh S; Siddiqui WA; Tripathi R
Parasitology; 2013 Mar; 140(3):406-13. PubMed ID: 23137860
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice.
Kimbi HK; Fagbenro-Beyioku AF; Oyibo WA
Indian J Malariol; 1998 Mar; 35(1):35-8. PubMed ID: 10319560
[No Abstract] [Full Text] [Related]
15. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs].
Xue J; Jiang B; Liu CS; Sun J; Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850
[TBL] [Abstract][Full Text] [Related]
16. Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.
Rafatro H; Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga-Urverg S; Rakoto-Ratsimamanga A; Frappier F
Biochem Pharmacol; 2000 May; 59(9):1053-61. PubMed ID: 10704934
[TBL] [Abstract][Full Text] [Related]
17. Poly ICLC enhances the antimalarial activity of chloroquine against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
Awasthi A; Mehrotra S; Bhakuni V; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1997 Jul; 17(7):419-23. PubMed ID: 9243375
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of resistant-reversal, CDRI compound 87/209 and its possible mode of action in rodent experimental malaria.
Srivastava R; Pandey VC; Bhaduri AP
Trop Med Parasitol; 1995 Jun; 46(2):83-7. PubMed ID: 8525290
[TBL] [Abstract][Full Text] [Related]
19. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
